REQUEST A DEMO
Total
USD $0.00
Search more companies

Rapiomed Group Sp. z o.o. (Poland)

Main Activities: General Medical and Surgical Hospitals
Full name: Rapiomed Group Sp. z o.o. Profile Updated: June 27, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Rapiomed Group Sp. z o.o. is a company based in Poland, with its head office in Warsaw. The enterprise currently operates in the General Medical and Surgical Hospitals sector. The company was established on September 15, 2017. From the latest financial highlights, Rapiomed Group Sp. z o.o. reported a net sales revenue increase of 18.49% in 2023. During that time, Rapiomed Group Sp. z o.o.’s total assets grew by 29.57%. The net profit margin of Rapiomed Group Sp. z o.o. increased by 6.46% in 2023.

Headquarters
Ul. Lucka 15/204
Warsaw; Mazowieckie; Postal Code: 00-842

Contact Details: Purchase the Rapiomed Group Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Rapiomed Group Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Rapiomed Group Sp. z o.o. report to view the information.
Incorporation Date:
September 15, 2017
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
33.33%
Company Performance
Financial values in the chart are available after Rapiomed Group Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
18.49%
Total operating revenue
18.49%
Operating profit (EBIT)
42.67%
EBITDA
42.23%
Net Profit (Loss) for the Period
43.02%
Total assets
29.57%
Total equity
39.73%
Operating Profit Margin (ROS)
6.65%
Net Profit Margin
6.46%
Return on Equity (ROE)
3.66%
Quick Ratio
1.03%
Cash Ratio
0.7%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?